Search：
All Dates：
- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
All Rooms：
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-13 (Saturday)
A1-A109
08:00-09:30
| Advancing Knowledge and Promoting Reform-Hepatocellular Carcinoma: Treatment Perspectives from Different Disciplines
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:10 |
FOLFOX HAIC：The New Regimen of Hepatic Arterial Infusion Chemotherapy for Large Hepatocellular Carcinoma |
Ming Shi | Sun Yat-sen University Cancer Center, China |
| 2 | 08:10-08:20 |
Dual hit: combination of TACE and Ablation in liver cancer |
Marcelo S. Guimaraes | Medical University of South Carolina, USA |
| 3 | 08:20-08:30 |
Systemic therapy of hepatocellular carcinoma: The gap between clinical trials and practice |
Xiu-Feng Liu | Jinling Hospital, Nanjing University, China |
| 4 | 08:30-08:40 |
Prediction model of survival in unresectable HCC with central bile duct invasion receiving TACE after biliary drainage |
Wen-Zhe Fan | The First Affiliated Hospital, Sun Yat-Sen University, China |
| 5 | 08:40-08:50 |
Brachytherapy using I125 seeds stand to treat HCC with HVTT |
Zi-Han Zhang | Zhongshan Hospital Affiliated to Fudan University, China |
| 6 | 09:00-09:30 |
Discussion |
A LL |
